Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa

Francesco Luzzaro, Andrea Endimiani, Jean Denis Docquier, Claudia Mugnaioli, Mattia Bonsignori, Gianfranco Amicosante, Gian Maria Rossolini, Antonio Toniolo

Research output: Contribution to journalArticlepeer-review

Abstract

The prevalence and the type(s) of metallo-β-lactamases (MBLs) produced by isolates of Pseudomonas aeruginosa were investigated. During 2001, 506 nonduplicate isolates were obtained from hospitalized patients. Eighty-two strains were selected because of resistance to carbapenems and/or ceftazidime. Screening for MBL production was performed in the latter isolates by the Etest MBL strips (AB Biodisk, Solna, Sweden) and by a broth microdilution method measuring minimum inhibitory concentrations (MICs) of imipenem alone and in the presence of metal-chelating agents (EDTA and o-phenanthroline). Specific DNA probes were used to investigate the presence of genes coding for IMP- or VIM-type enzymes. Overall, four isolates of P. aeruginosa (obtained from independent patients) were found to carry a blaVIM gene. Polymerase chain reaction (PCR) experiments and DNA sequencing revealed that the VIM-2 determinant was present in three cases, whereas VIM-1 was detected in one isolate. Surveillance programs should be adopted to avoid the spread of these worrisome resistance genes.

Original languageEnglish
Pages (from-to)131-135
Number of pages5
JournalDiagnostic Microbiology and Infectious Disease
Volume48
Issue number2
DOIs
Publication statusPublished - Feb 2004

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Virology
  • Parasitology
  • Microbiology
  • Immunology
  • Applied Microbiology and Biotechnology

Fingerprint Dive into the research topics of 'Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this